{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T07:23:43Z","timestamp":1700637823464},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,25]],"date-time":"2008-10-25T00:00:00Z","timestamp":1224892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s11547-008-0333-y","type":"journal-article","created":{"date-parts":[[2008,10,27]],"date-time":"2008-10-27T17:24:10Z","timestamp":1225128250000},"page":"141-151","source":"Crossref","is-referenced-by-count":4,"title":["Ultrasonographic assessment of lipodystrophy in HIV-1-infected patients"],"prefix":"10.1007","volume":"114","author":[{"given":"P. F.","family":"Grima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Chiavaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Grima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,25]]},"reference":[{"key":"333_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"F.J. Palella","year":"1998","unstructured":"Palella FJ, Delaney KM, Moorman AC et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient Study Investigators. N Engl J Med 338:853\u2013860","journal-title":"N Engl J Med"},{"key":"333_CR2","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","volume":"13","author":"G. Behrens","year":"1999","unstructured":"Behrens G, Dejam A, Schmidt H et al (1999) Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 13:F63\u2013F70","journal-title":"AIDS"},{"key":"333_CR3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","volume":"356","author":"A. Carr","year":"2000","unstructured":"Carr A, Cooper DA. (2000) Adverse effects of antiretroviral therapy. Lancet 356:1423\u20131430","journal-title":"Lancet"},{"key":"333_CR4","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A. Carr","year":"1988","unstructured":"Carr A, Samaras K, Burton S et al (1988) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51\u2013F58","journal-title":"AIDS"},{"key":"333_CR5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"K.A. Lichtenstein","year":"2001","unstructured":"Lichtenstein KA, Ward DJ, Moorman AC et al (2001) Clinical assessment of HIV associated lipodystrophy in an ambulatory population. AIDS 15:1389\u20131398","journal-title":"AIDS"},{"key":"333_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00001432-200202000-00003","volume":"15","author":"A. Schwenk","year":"2002","unstructured":"Schwenk A (2002) Methods of assessing body shape and composition in HIV associated lipodystrophy. Curr Opin Infect Dis 15:9\u201316","journal-title":"Curr Opin Infect Dis"},{"key":"333_CR7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A. Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A et al (1999) Diagnosis, prediction, and natural course of HIV-1 proteaseinhibitor-associated lipodistrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353:2093\u20132099","journal-title":"Lancet"},{"key":"333_CR8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(00)02850-6","volume":"356","author":"E. Martinez","year":"2000","unstructured":"Martinez E, Bianchi L, Garcia-Viejo MA et al (2000) Sonographic assessment of regional fat in HIV-infected people. Lancet 356:1412\u20131413","journal-title":"Lancet"},{"key":"333_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","volume":"14","author":"T. Saint-Marc","year":"2000","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I et al (2000) Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 14:37\u201349","journal-title":"AIDS"},{"key":"333_CR10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","volume":"17","author":"P.W.G. Mallon","year":"2003","unstructured":"Mallon PWG, Miller J, Cooper DA, Carr A (2003) Prospective evaluation of the effect of antiretroviral therapy on body composition in HIV-1 infected men starting therapy. AIDS 17:971\u2013979","journal-title":"AIDS"},{"key":"333_CR11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.aids.0000216388.37610.6c","volume":"20","author":"R. Gulizia","year":"2006","unstructured":"Gulizia R, Vercelli A, Gervasoni C et al (2006) Controversy concerning role of ultrasonographic lipoatrophy assessments in HIV patients. AIDS 20:789\u2013790","journal-title":"AIDS"},{"key":"333_CR12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","volume":"5","author":"G.J. Moyle","year":"2004","unstructured":"Moyle GJ, Lysakova L, Brown S et al (2004) A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5:82\u201387","journal-title":"HIV Med"},{"key":"333_CR13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/421774","volume":"39","author":"V. Asensi","year":"2004","unstructured":"Asensi V, Martin-Roces ER, Carton JA et al (2004) Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV-type 1 infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 39:240\u2013247","journal-title":"Clin Infect Dis"},{"key":"333_CR14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/aid.2006.22.830","volume":"22","author":"V. Asensi","year":"2006","unstructured":"Asensi V, Martin-Roces ER, Collazos J et al (2006) Association between physical and Echographic fat thickness assessments and a lipodystrophy grading scale in lipodystrophic HIV patients: pratical implications. AIDS Res Hum Retroviruses 22:830\u2013836","journal-title":"AIDS Res Hum Retroviruses"},{"key":"333_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00126334-200212010-00006","volume":"31","author":"J. Blanch","year":"2002","unstructured":"Blanch J, Rousaud A, Martinez E et al (2002) Impact of lipodystrophy on the quality of life of HIV-1 infected patients. J Acquir Immune Defic Syndr 31:404\u2013407","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"[Suppl2]","key":"333_CR16","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1086\/367563","volume":"36","author":"F. Satler","year":"2003","unstructured":"Satler F (2003) Body habitus changes related to lipodystrophy. Clin Infect Dis 36[Suppl 2]:S84\u2013S90","journal-title":"Clin Infect Dis"},{"key":"333_CR17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.apnr.2004.09.006","volume":"17","author":"I.B. Coress","year":"2004","unstructured":"Coress IB, Nicholas PK, McGibbon CA et al (2004) Weight change, body image, and quality of life in HIV disease: a pilot study. Appl Nurs Res 17:292\u2013296","journal-title":"Appl Nurs Res"},{"key":"333_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11136-004-2580-2","volume":"14","author":"R. Burgoyne","year":"2005","unstructured":"Burgoyne R, Collins E, Wagner C et al.(2005) The relation between lipodystrophy associated body changes and measures of quality of life and mental health for HIV-positive adults. Qual Life Res 14:981\u2013990","journal-title":"Qual Life Res"},{"key":"333_CR19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/01.aids.0000180106.11383.cc","volume":"19","author":"D. Carey","year":"2005","unstructured":"Carey D, Wand H, Martin A et al (2005) Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial. AIDS 19:1325\u20131327","journal-title":"AIDS"},{"key":"333_CR20","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1097\/00002030-200009080-00025","volume":"14","author":"H. Zylberger","year":"2000","unstructured":"Zylberger H, Nalpas B, Pol S et al (2000) Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy? AIDS 14:2055\u20132065","journal-title":"AIDS"},{"key":"333_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00126334-200203010-00015","volume":"29","author":"C. Torti","year":"2002","unstructured":"Torti C, Patroni A, Tinelli C et al (2002) Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 29:315\u2013317","journal-title":"J Acquir Immune Defic Syndr"},{"key":"333_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00126334-200303010-00018","volume":"32","author":"A. Rodriguez-Guardado","year":"2003","unstructured":"Rodriguez-Guardado A, Maradona JA, Asensi V et al (2003) Hepatitis C in patients with HIV infection and lipodystrophy. J Acquir Immune Defic Syndr 32:348\u2013349","journal-title":"J Acquir Immune Defic Syndr"},{"key":"333_CR23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","volume":"6","author":"M.S. Sulkowski","year":"2005","unstructured":"Sulkowski MS, Mehta SH, Torbenson M et al (2005) Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS 6:585\u2013592","journal-title":"AIDS"},{"issue":"[Suppl2]","key":"333_CR24","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1086\/381499","volume":"38","author":"S. Pol","year":"2004","unstructured":"Pol S, Lebray P, Vallet-Pichard A (2004) HIV infection and hepatic enzyme abnormalities: intrincacies of the pathogenic mechanisms. Clin Infect Dis 38[Suppl 2]:S65\u2013S72","journal-title":"Clin Infect Dis"},{"key":"333_CR25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-133-3-200008010-00010","volume":"133","author":"K.D. Miller","year":"2000","unstructured":"Miller KD, Cameron M, Wood LV et al (2000) Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med 133:192\u2013196","journal-title":"Ann Intern Med"},{"key":"333_CR26","first-page":"1433","volume":"90","author":"I.S. Fortgang","year":"1995","unstructured":"Fortgang IS, Belitsos PC, Chaisson RE et al (1995) Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol 90:1433\u20131436","journal-title":"Am J Gastroenterol"},{"key":"333_CR27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","volume":"126","author":"A. Lonardo","year":"2004","unstructured":"Lonardo A, Adinolfi LE, Loria P et al (2004) Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 126:586\u2013597","journal-title":"Gastroenterology"},{"key":"333_CR28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00126334-200308150-00005","volume":"33","author":"S.H. Mehta","year":"2003","unstructured":"Mehta SH, Moore RD, Thomas DL et al (2003) The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. J Acquir Immune Defic Syndr 33:577\u2013584","journal-title":"J Acquir Immune Defic Syndr"},{"key":"333_CR29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1086\/426145","volume":"40","author":"R. Gulizia","year":"2005","unstructured":"Gulizia R, Brunetti E, Gervasoni C et al (2005) Sonographic assessment of lipodystrophy in HIV-infected patients: some open questions. Clin Infect Dis 40:323\u2013324","journal-title":"Clin Infect Dis"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-008-0333-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-008-0333-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-008-0333-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:32:33Z","timestamp":1559392353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-008-0333-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1007\/s11547-008-0333-y","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,25]]}}}